
KYPROLIS®+Darzalex® (daratumumab) and dexamethasone (DKd) Regimen
Learn more about how a DKd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the CANDOR study (DKd vs Kd).
Learn more about how a DKd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the CANDOR study (DKd vs Kd).
Learn more about how a KRd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the ASPIRE study (KRd vs Rd).
Learn more about how a Kd regimen may benefit appropriate adult patients with relapsed multiple myeloma. Includes results from the ENDEAVOR study (Kd vs Vd).
Get important data from the CANDOR study (DKd vs Kd) and a DKd regimen for appropriate adult patients with relapsed multiple myeloma.
Review a hypothetical case study of a patient with multiple myeloma at first relapse and learn about her DKd treatment plan.
Learn about the appropriate dosing for each regimen containing KYPROLIS®.
Please see full Prescribing Information.
See the CANDOR study (DKd vs Kd) data and learn how appropriate adult patients with relapsed multiple myeloma may benefit from a DKd regimen.
Learn more about the CANDOR study (DKd vs Kd) and how DKd may help your adult patients with relapsed multiple myeloma.